Cytokinetics Incorporated Asset Turnover Ratio (CYTK), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cytokinetics Incorporated  (NASDAQ: CYTK)
 

Cytokinetics Incorporated Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2026, Cytokinetics Incorporated's asset turnover ratio sequentially decreased to 0.04 in the second quarter (Jun 30 2026), this is lower than usual.

Within sector 173 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 917 to 3256.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYTK Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 174.83 % 0.68 % 1.55 % 0.01 % -19.6 %
Y / Y Revenue Change -57.13 % 1125.78 % 4.89 % 318.14 % 26714.86 %
Asset Turnover Ratio (TTM) 0.04 0.08 0.07 0.07 0.06
CYTK's Total Ranking # 3256 # 917 # 2947 # 917 # 2985
Seq. Asset Change 164.57 % -10.6 % -0.88 % 17.23 % -3.08 %
Seq. Revenue Change 47.89 % 9.01 % 817.1 % -97.1 % 4128.56 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 174
Healthcare Sector # 512
Overall Market # 3256

Asset Turnover Ratio Statistics
High Average Low
0.78 0.18 0
(Dec 31 2016)   (Sep 30 2024)




CYTK Company Profile • Back to CYTK Efficiency Comparisons • Compare CYTK Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Nexalin Technology Inc   0.05 $ 0.217  Millions$ 4.115  Millions
Prophase Labs Inc   0.05 $ 3.150  Millions$ 60.428  Millions
Alector Inc   0.05 $ 13.863  Millions$ 267.823  Millions
Seer Inc   0.05 $ 14.377  Millions$ 283.365  Millions
Abcellera Biologics Inc   0.05 $ 66.174  Millions$ 1,331.907  Millions
Monte Rosa Therapeutics Inc   0.05 $ 28.727  Millions$ 584.022  Millions
Insight Molecular Diagnostics Inc   0.05 $ 1.670  Millions$ 34.891  Millions
Dar Bioscience Inc   0.05 $ 1.345  Millions$ 28.355  Millions
Nakamoto Inc   0.05 $ 28.962  Millions$ 616.576  Millions
Agape Atp Corporation  0.05 $ 1.152  Millions$ 24.729  Millions
Aclaris Therapeutics Inc   0.05 $ 8.219  Millions$ 178.602  Millions
Cytokinetics Incorporated  0.04 $ 67.670  Millions$ 1,514.781  Millions
Instil Bio Inc   0.04 $ 8.968  Millions$ 203.358  Millions
Camp4 Therapeutics Corporation  0.04 $ 4.216  Millions$ 100.772  Millions
Recursion Pharmaceuticals Inc   0.04 $ 54.855  Millions$ 1,356.462  Millions
Vistagen Therapeutics Inc   0.04 $ 2.501  Millions$ 62.393  Millions
Kyntra Bio Inc   0.04 $ 4.617  Millions$ 116.829  Millions
X4 Pharmaceuticals Inc  0.04 $ 9.441  Millions$ 244.340  Millions
Blue Water Vaccines Inc  0.03 $ 0.646  Millions$ 18.966  Millions
Pluri Inc   0.03 $ 1.016  Millions$ 30.822  Millions
Tscan Therapeutics Inc   0.03 $ 7.111  Millions$ 216.114  Millions
Northwest Biotherapeutics Inc  0.03 $ 2.173  Millions$ 66.973  Millions
Tao Synergies Inc   0.03 $ 0.772  Millions$ 24.086  Millions
Atrium Therapeutics Inc   0.03 $ 35.974  Millions$ 1,166.283  Millions
Bioage Labs Inc   0.03 $ 10.355  Millions$ 348.641  Millions
Co diagnostics Inc   0.03 $ 0.721  Millions$ 26.893  Millions
Dbv Technologies S a   0.02 $ 5.018  Millions$ 223.351  Millions
Fate Therapeutics Inc   0.02 $ 6.491  Millions$ 301.907  Millions
Medicinova Inc   0.02 $ 0.920  Millions$ 44.080  Millions
Mangoceuticals Inc   0.02 $ 0.315  Millions$ 15.311  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.